EMP2 is a novel therapeutic target for endometrial cancer stem cells

Previous studies have suggested that overexpression of the oncogenic protein epithelial membrane protein-2 (EMP2) correlates with endometrial carcinoma progression and ultimately poor survival from disease. To understand the role of EMP2 in the etiology of disease, gene analysis was performed to sho...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncogene
Asıl Yazarlar: Kiyohara, Meagan H., Dillard, Christen, Tsui, Jessica, Kim, Sara Ruth, Lu, Jianyi, Sachdev, Divya, Goodglick, Lee, Tong, Maomeng, Torous, Vanda Farahmand, Aryasomayajula, Chinmayi, Wang, Wei, Najafzadeh, Parisa, Gordon, Lynn K., Braun, Jonathan, McDermott, Sean, Wicha, Max S., Wadehra, Madhuri
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5648618/
https://ncbi.nlm.nih.gov/pubmed/28604744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2017.142
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller